Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy
about
New perspectives in glioblastoma antiangiogenic therapyCombined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivoNext generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trialCombined efficacy of cediranib and quinacrine in glioma is enhanced by hypoxia and causally linked to autophagic vacuole accumulation.Glial progenitors as targets for transformation in glioma.NT113, a pan-ERBB inhibitor with high brain penetrance, inhibits the growth of glioblastoma xenografts with EGFR amplification.Dendritic cell immunotherapy versus bevacizumab plus irinotecan in recurrent malignant glioma patients: a survival gain analysis.Sunitinib enhances neuronal survival in vitro via NF-κB-mediated signaling and expression of cyclooxygenase-2 and inducible nitric oxide synthase.Immune-checkpoint blockade and active immunotherapy for glioma.Cell surface membrane proteins as personalized biomarkers: where we stand and where we are headed.EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy.Temozolomide resistance in glioblastoma cells occurs partly through epidermal growth factor receptor-mediated induction of connexin 43.A data mining approach for identifying pathway-gene biomarkers for predicting clinical outcome: A case study of erlotinib and sorafenib.Valproic acid sensitizes human glioma cells to gefitinib-induced autophagy.Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment.AG488 as a therapy against gliomas.Sunitinib tissue distribution changes after coadministration with ketoconazole in mice.Influences of Anlotinib on Cytochrome P450 Enzymes in Rats Using a Cocktail Method.
P2860
Q26746028-BD2A5F38-0D58-477F-ADB3-27F8D4504D7DQ33720256-48A3C6E3-B164-4871-A81C-64C6633B8739Q34544846-D22D71AB-8653-4D79-BD7D-26AE29C3D70EQ34662536-991AC557-65CD-4888-A28A-3AF7C9DD247DQ34735661-B5B13354-5E35-403E-B013-C461321C6D7EQ35190966-1696EFA3-44E0-466F-8922-B745EB727D1FQ36201736-BD5E2415-2DD3-44C7-9778-14E48A1EE026Q37053448-BAF7AE01-02B1-4927-A82F-F4680E19C6C9Q37420586-75017EB3-38A4-42A2-8662-320B2F6536C5Q38138610-380F767E-650D-489D-B459-8C99F8F06C95Q38199643-0A9E1967-4051-43D2-A48E-2366154EC193Q38593312-520ECF1B-D665-4097-80D0-F0F509A9EE65Q38632417-1389BB48-E2E6-4C1E-87B9-F0CB0D7BD42DQ38826168-5C3F5B9A-48DC-4F68-B254-B327474D43FCQ38933860-1417450C-EDC2-4713-8F9A-20D66EF47D38Q42700872-2D8DB807-7754-4BEC-A87B-56F7D9B12008Q48341764-A2FE43B3-B1BD-4FDA-94BD-918C4AC33294Q49449657-6F2BD900-36FB-41AF-BF08-237F26F1B4EC
P2860
Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy
@ast
Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy
@en
Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy
@nl
type
label
Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy
@ast
Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy
@en
Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy
@nl
prefLabel
Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy
@ast
Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy
@en
Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy
@nl
P2093
P2860
P3181
P1433
P1476
Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy
@en
P2093
Avadhut D Joshi
Betty Tyler
Gary L Gallia
Gregory J Riggins
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0044372
P407
P577
2012-01-01T00:00:00Z